Stock Updates

How has Teva Pharmaceutical Industries Limited:(NYSE:TEVA) performed recently?

Teva Pharmaceutical Industries Limited (NYSE: TEVA) is a large market cap stock with a market cap of 53589.08. It is in the Drug Manufacturers – Other industry and sector Healthcare, with a current P/E of 35.95, a forward P/E of 8.83 and EPS of 1.5. At a stock price of 54.33 (0.88%) it has a dividend yield of 2.53%.

EPS growth for the last five years have been -13.10%, more recently this last year it has grown by -48.90%. The next year growth is going to be about 15.36% and more long-term 5.78% after five years. EPS growth quarter over quarter is -67.40%. Sales growth for the past five years have been 4.00% and sales growth quarter over quarter is 1.40%.

For performance, Teva Pharmaceutical Industries Limited the past week has seen a gain of -0.65%. For the last month performance for Teva Pharmaceutical Industries Limited is -2.04%. While the last quarter is 7.79% and half year, -2.16%. Finally for the year, performance is -20.50%.

The 52-week high for Teva Pharmaceutical Industries Limited, is at -21.03%, and for the 52-week low it comes to a value of 13.17%. The 20-day simple moving average is 2.93% and -4.11% for the 200-day simple moving average.

Volatility for the week is at 1.96%, and for the month it is 1.96%. Teva Pharmaceutical Industries Limited, has a target price of 69.95.

In terms of debt, long term debt/equity is 0.27, and for total debt/equity Teva Pharmaceutical Industries Limited has 0.36. The gross margin is 57.70%, while operating margin is 17.70%, the profit margin is 6.90%. The current ratio is 1.3 and the quick ratio is 1.

Insider ownership is at 2.70%, with instituitional ownership at 69.10%. Teva Pharmaceutical Industries Limited has a payout ratio of 67.50%. With the total shares outstanding coming to 994.97. The shares float is 994.97, with the float short at 2.09%, with short ratio coming to 3.76.

In terms of returns, the return on assets see Teva Pharmaceutical Industries Limited, get 2.50%, with its returns on investment at 5.70%. Return on equity is 4.90%. So will the investors see the target price of 69.95, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Stephen Butters

Leave a Comment